Allogene Therapeutics Inc Capital Reinvestment Ratio

Latest as of March 2018: 275.40x

Allogene Therapeutics Inc capital reinvestment ratio. Allogene Therapeutics Inc (ALLO) has a Capital Reinvestment Ratio of 275.40x as of March 2018, meaning it reinvests 275% of its operating cash flow ($5.00K) in capital expenditures ($1.38 Million). See cash generation quality of Allogene Therapeutics Inc to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

275.40x

Capex / Operating Cash Flow

Operating Cash Flow

$5.00K

USD

Capital Expenditures

$1.38 Million

USD

Data as of

Mar 2018

Most recent filing

Allogene Therapeutics Inc Capital Reinvestment Ratio by Year (None–None)

Allogene Therapeutics Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see how efficiently does Allogene Therapeutics Inc generate cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow